Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin, Benjamin Bates, Qianqian Song, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2232-2246
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

COVID-19 Emotional and Mental Impact on Cancer Patients Receiving Radiotherapy: An Interpretation of Potential Explaining Descriptors
Maria Tolia, Emmanouil K. Symvoulakis, Emmanouil Matalliotakis, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 586-597
Open Access | Times Cited: 6
COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 545-545
Open Access | Times Cited: 6
Risk of COVID‐19 death for people with a pre‐existing cancer diagnosis prior to COVID‐19‐vaccination: A systematic review and meta‐analysis
Julia Steinberg, Suzanne Hughes, Harriet Hui, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 8, pp. 1394-1412
Open Access | Times Cited: 6
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry
Marie‐Kristin Tilch, Carlo Visco, Sandra Bašić‐Kinda, et al.
HemaSphere (2022) Vol. 6, Iss. 5, pp. e0711-e0711
Open Access | Times Cited: 10
COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies
Jason D. Goldman, Michael A. Gonzalez, Maria Madeleine Rüthrich, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 176-188
Open Access | Times Cited: 10
In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States
Ziad Abuhelwa, Anas Alsughayer, Ahmad Y. Abuhelwa, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 222-222
Open Access | Times Cited: 10
Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients
Maria Silvia Cona, Agostino Riva, Davide Dalu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 12, pp. 12967-12974
Open Access | Times Cited: 5
Updated COVID‐19 clearance time among patients with cancer in the Delta and Omicron waves
Zachary M. Avigan, Rodrigo Paredes, Leora Boussi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16869-16875
Open Access | Times Cited: 5
16 Months Follow Up of Patients’ Behavior and Mild COVID-19 Patterns in a Large Cohort of Cancer Patients During the Pandemic
Nawale Hajjaji, Kathleen Lepoutre, Sarra Lakhdar, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
A population-based study of COVID-19 mortality risk in US cancer patients
Kyle Mani, Xue Wu, Daniel E. Spratt, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 8, pp. 1288-1293
Closed Access | Times Cited: 1
Deviation from standard cancer treatment during the first wave of the COVID-19 pandemic in India
Vanita Noronha, Darshit Shah, Smruti Mokal, et al.
Cancer Research Statistics and Treatment (2022) Vol. 5, Iss. 2, pp. 212-219
Open Access | Times Cited: 8
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans
Harshraj Leuva, Mengxi Zhou, Norbert Bräu, et al.
Seminars in Oncology (2022) Vol. 49, Iss. 5, pp. 363-370
Open Access | Times Cited: 8
Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
Nathaniel B. Verhagen, Nicolas K. Koerber, Anikó Szabó, et al.
Annals of Surgical Oncology (2022) Vol. 30, Iss. 3, pp. 1305-1308
Open Access | Times Cited: 8
Patient and carer experiences of lung cancer referral pathway in a regional health service: a qualitative study
Zulfiquer Otty, Amy Brown, Sarah Larkins, et al.
Internal Medicine Journal (2023) Vol. 53, Iss. 11, pp. 2016-2027
Open Access | Times Cited: 4
Cancer, more than a “COVID-19 co-morbidity”
Chinmay Jani, Robert T. Schooley, Rana R. McKay, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study
Sebastián Mondaca, Benjamín Walbaum, Nicole Le Corre, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1193-1193
Open Access | Times Cited: 4
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
Amit Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic
Fareed Khawaja, Georgios Angelidakis, Adina L. Feldman, et al.
Cancer Medicine (2023) Vol. 12, Iss. 24, pp. 22006-22022
Open Access | Times Cited: 4
A retrospective analysis of 902 hospitalized COVID‐19 patients in Lebanon: clinical epidemiology and risk factors
Fatima Dakroub, Suha Fakhredine, Mohammad Yassine, et al.
Journal of Clinical Virology Plus (2021) Vol. 1, Iss. 4, pp. 100048-100048
Open Access | Times Cited: 10
COVID‐19 outcomes in patients with cancer: Findings from the University of California health system database
Daniel H. Kwon, José Cadena, Sam Nguyen, et al.
Cancer Medicine (2022) Vol. 11, Iss. 11, pp. 2204-2215
Open Access | Times Cited: 6
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
Lilith Faucheux, Lucas Bassolli de Oliveira Alves, Sylvie Chevret, et al.
Hematology Transfusion and Cell Therapy (2022) Vol. 45, Iss. 3, pp. 306-316
Open Access | Times Cited: 6
The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and Concerns
Lisa Grech, Bao Sheng Loe, Daphne Day, et al.
Behavioral Medicine (2022) Vol. 49, Iss. 4, pp. 402-411
Closed Access | Times Cited: 6
Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin
Margaret Nolan, Thomas M. Piasecki, Stevens S. Smith, et al.
Cancer Epidemiology Biomarkers & Prevention (2022) Vol. 32, Iss. 1, pp. 12-21
Open Access | Times Cited: 6
Risk of Underlying Diseases and Effectiveness of Drugs on COVID-19 Inpatients Assessed Using Medical Claims in Japan: Retrospective Observational Study
Shingo Mitsushima, Hiromasa Horiguchi, Kiyosu Taniguchi
International Journal of General Medicine (2023) Vol. Volume 16, pp. 657-672
Open Access | Times Cited: 3
Evolving oncology care for older adults: Trends in telemedicine use after one year of caring for older adults with cancer during COVID-19
Mariuxi A Viteri Malone, Leana Cabrera Chien, Mackenzi Pergolotti, et al.
Journal of Geriatric Oncology (2023) Vol. 14, Iss. 6, pp. 101497-101497
Open Access | Times Cited: 3

Scroll to top